Attitudes of clinicians about screening head and neck cancer survivors for lung cancer using low-dose computed tomography
Annals of Otology, Rhinology & Laryngology Dec 12, 2019
Dukes K, Seaman AT, Hoffman RM, et al. - In view of national guidelines recommending lung cancer screening (LCS) utilizing low-dose CT (LDCT) for high-risk patients, including survivors of other tobacco-related cancers like head and neck cancer (HNC), researchers conducted this qualitative study investigating clinicians’ practices and attitudes toward LCS with LDCT with patients who have survived HNC, in the context of mandated necessities for shared decision making (SDM) using decision aids. They performed a thematic analysis of transcribed semi-structured clinician interviews and focus groups. Clinicians reported LCS as useful for some HNC survivors with smoking histories. However, many challenges to SDM in different clinic settings are encountered, including time, workflow, uncertainty about guidelines and reimbursement, decision aids, competing patient priorities, unclear evidence, potentially heightened patient receptivity and stress, and the complexity of discussions. Further, they encountered challenges in LCS implementation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries